RYCRX
Price
$33.83
Change
+$0.20 (+0.59%)
Updated
Oct 17 closing price
Net Assets
1.93M
VGSLX
Price
$129.22
Change
+$0.83 (+0.65%)
Updated
Oct 17 closing price
Net Assets
65.68B
Interact to see
Advertisement

RYCRX vs VGSLX

Header iconRYCRX vs VGSLX Comparison
Open Charts RYCRX vs VGSLXBanner chart's image
Rydex Real Estate C
Price$33.83
Change+$0.20 (+0.59%)
VolumeN/A
Net Assets1.93M
Vanguard Real Estate Index Admiral
Price$129.22
Change+$0.83 (+0.65%)
VolumeN/A
Net Assets65.68B
RYCRX vs VGSLX Comparison Chart in %
View a ticker or compare two or three
VS
RYCRX vs. VGSLX commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYCRX is a Hold and VGSLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VGSLX has more cash in the bank: 65.7B vs. RYCRX (1.93M). VGSLX pays higher dividends than RYCRX: VGSLX (3.86) vs RYCRX (0.93). RYCRX was incepted earlier than VGSLX: RYCRX (22 years) vs VGSLX (24 years). RYCRX (2.43) is less costly to investors than VGSLX (0.13). RYCRX is a more actively managed with annual turnover of: 344.00 vs. VGSLX (7.00). RYCRX has a lower initial minimum investment than VGSLX: RYCRX (2500) vs VGSLX (3000). VGSLX annual gain was more profitable for investors over the last year : -2.09 vs. RYCRX (-2.77). VGSLX return over 5 years is better than : 36.78 vs. RYCRX (30.89).
RYCRXVGSLXRYCRX / VGSLX
Total Expense Ratio2.380.131,831%
Annual Report Gross Expense Ratio2.430.131,869%
Fund Existence22 years24 years-
Gain YTD4.4145.34583%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets1.93M65.7B0%
Annual Yield % from dividends0.933.8624%
Returns for 1 year-2.77-2.09133%
Returns for 3 years24.6429.3884%
Returns for 5 years30.8936.7884%
Returns for 10 years37.8559.0264%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INTA37.130.56
+1.53%
Intapp
SW41.400.08
+0.19%
Smurfit WestRock plc
GMGI0.96-0.01
-0.86%
Golden Matrix Group
ATXS11.98-0.11
-0.91%
Astria Therapeutics
LYRA6.90-0.25
-3.47%
Lyra Therapeutics Inc